Parmax Pharma Ltd.

BSE: 540359

₹131.15

up-down-arrow1.25 (0.96%)

As on 24-Aug-2026IST

Market cap

info icon

₹49 Cr

Revenue (TTM)

info icon

₹18 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

-10.5

Div. Yield

info icon

0 %

Parmax Pharma Share Price

Compare

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 131.15 High: 131.15

52 Week Range

Low: 22.60 High: 131.15

Liquidityliquidity Low

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹-1 Cr

  • ROEROE information

    0 %

  • ROCEROCE information

    -29.9 %

  • Industry P/EIndustry P/E information

    47.41

  • EV/EBITDAEV/EBITDA information

    -154.5

  • Debt to EquityDebt to Equity information

    -4.1

  • Book ValueBook Value information

    ₹--

  • EPSEPS information

    ₹-3.2

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    3,741,300

10 Years Aggregate

CFO

₹10.57 Cr

EBITDA

₹8.98 Cr

Net Profit

₹-6.56 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Parmax Pharma
287.7 25.0 261.9 256.5 65.0 30.7 --
BSE Commodities*
9.7 2.7 -1.2 13.5 16.4 9.7 14.0
As on 24-Aug-2026  |  *As on 28-Aug-2026
Company
2025
2024
2023
2022
2021
Parmax Pharma
-23.5 36.3 -15.8 -35.4 111.0
BSE Small Cap
-6.6 29.0 47.5 -1.8 62.8
BSE Commodities
12.5 8.1 17.5 1.2 61.5

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Parmax Pharma
131.2 49.1 18.4 -1.2 -20.4 -- -- -10.5
540.4 19,601.8 9,013.0 531.0 9.4 9 36.9 3.2
1,696.8 22,521.3 1,223.9 235.2 25.4 10 95.8 9.0
1,762.9 24,046.8 8,574.8 783.4 12.8 14 30.7 3.9
5,282.5 16,175.3 2,471.6 442.5 19.3 17 36.9 5.8
7,224.5 16,798.7 2,258.2 387.9 19.9 15 43.3 6.0
673.0 33,955.3 4,974.3 804.1 18.7 18.2 42.5 6.9
IEL
5.8 75.1 1.5 1.5 74.4 3.4 50.3 1.6
195.8 15,835.9 8,263.5 588.7 9.2 9.8 26.4 2.3
156.0 49.6 35.1 5.9 16.2 14.8 8.4 1.2

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About Parmax Pharma

Manufacture of allopathic pharmaceutical preparations

  • Incorporated

    1994

  • Chairman

    --

  • Managing Director

    Umang A Gosalia

  • Headquarters

    Rajkot, Gujarat

  • Website

    www.parmaxpharma.com

FAQs for Parmax Pharma

The share price of Parmax Pharma Ltd is ₹131.15 (BSE) as of 24-Aug-2026 IST. Parmax Pharma Ltd has given a return of 65.03% in the last 3 years.

Since, TTM earnings of Parmax Pharma Ltd is negative, P/E ratio is not available.
The P/B ratio of Parmax Pharma Ltd is -10.54 times as on 24-Aug-2026, a 233 discount to its peers’ median range of 7.90 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
0.00
-5.86
2024
0.00
-17.63
2023
0.00
2.39
2022
108.00
3.43
2021
17.61
3.39

The 52-week high and low of Parmax Pharma Ltd are Rs 131.15 and Rs 22.60 as of 29-Aug-2026.

Parmax Pharma Ltd has a market capitalisation of ₹ 49 Cr as on 24-Aug-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Parmax Pharma Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...
loading...
loading...